Tag: Market
RSV Prophylactic Beyfortus: Potential Competitors and Market Trends
Alnylam Pharmaceuticals, led by CEO Yvonne Greenstreet, is making strides in expanding the use of its RNA-based gene-silencing heart drug, vutrisiran. The drug has...
BREAKING NEWS
NYU School of Global Public Health Wins STAT Madness Vote
In a spirited celebration of scientific discovery, the recent STAT Breakthrough Summit East in Manhattan hosted a unique event that drew parallels to the...
